Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
05/05/20103:01PMBusiness WireImmunoGen, Inc. Announces Proposed Public Offering of Common StockNASDAQ:IMGNImmunoGen Inc
04/29/20103:09PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IMGNImmunoGen Inc
04/29/20103:01PMBusiness WireImmunoGen, Inc. Reports Third Quarter Fiscal Year 2010 Financial ResultsNASDAQ:IMGNImmunoGen Inc
04/23/20105:00AMEdgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:IMGNImmunoGen Inc
04/22/20104:04PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(2) (424B2)NASDAQ:IMGNImmunoGen Inc
04/22/20105:30AMBusiness WireImmunoGen, Inc. Announces Conference Call to Discuss its Third Quarter Fiscal Year 2010 Financial ResultsNASDAQ:IMGNImmunoGen Inc
04/19/20107:15AMGlobeNewswire Inc.Emerging Stock Report Initiates Independent Research Coverage on Immunogen, Inc.NASDAQ:IMGNImmunoGen Inc
04/15/201012:01AMBusiness WireImmunoGen, Inc. Announces Favorable Update Provided by Roche Related to Its Trastuzumab-DM1 Regulatory PlansNASDAQ:IMGNImmunoGen Inc
04/09/201012:52PMEdgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:IMGNImmunoGen Inc
04/09/201012:50PMEdgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:IMGNImmunoGen Inc
04/01/20109:56AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
03/18/201010:15AMBusiness WireImmunoGen, Inc. Announces Webcast of Presentation at the 2010 Barclays Capital Global Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
03/08/20103:01PMBusiness WireImmunoGen, Inc. Announces Orphan Drug Designation Granted to IMGN901 for Treatment of Merkel Cell Carcinoma by US FDA & EU COMPNASDAQ:IMGNImmunoGen Inc
03/08/201010:45AMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:IMGNImmunoGen Inc
03/01/20105:30AMBusiness WireImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor ConferencesNASDAQ:IMGNImmunoGen Inc
02/16/20103:25PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:IMGNImmunoGen Inc
02/16/201012:02PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:IMGNImmunoGen Inc
02/05/20109:51AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/05/20109:50AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/03/20109:30AMBusiness WireImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 25, 2010NASDAQ:IMGNImmunoGen Inc
02/02/20105:30AMBusiness WireImmunoGen, Inc. Announces Webcast of Presentation at the 12th Annual BIO CEO & Investor ConferenceNASDAQ:IMGNImmunoGen Inc
01/29/20101:52PMEdgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:IMGNImmunoGen Inc
01/29/20108:36AMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:IMGNImmunoGen Inc
01/28/20103:06PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IMGNImmunoGen Inc
01/28/20103:01PMBusiness WireImmunoGen, Inc. Reports Second Quarter Fiscal Year 2010 Financial ResultsNASDAQ:IMGNImmunoGen Inc
01/21/20105:30AMBusiness WireImmunoGen, Inc. Announces Conference Call to Discuss Its Second Quarter Fiscal Year 2010 Financial ResultsNASDAQ:IMGNImmunoGen Inc
01/07/201010:17AMEdgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:IMGNImmunoGen Inc
01/06/20108:25AMBusiness WireImmunoGen, Inc. Announces Webcast of Presentation at the 28th Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
12/21/20091:57PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMGNImmunoGen Inc
12/17/20093:01PMBusiness WireImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & QualityNASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN

Your Recent History

Delayed Upgrade Clock